Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Jorge Yoshinori Shida"'
Autor:
André Mattar, Murilo Barato Agudo Romão, Luiz Henrique Gebrim, Guilherme Ribeiro Fonseca, Debbie M Jakubowski, Maria C S Bastos, Maria Antonieta Longo Galvão Silva, Monica Maria Agata Stiepcich, Sergio C Oliveira, Fabio Bagnoli, José Francisco Rinaldi, Jorge Yoshinori Shida, Calvin Chao, Vilmar Marques de Oliveira
Publikováno v:
JCO Global Oncology
PURPOSE We evaluated the impact of 21-gene test results on treatment decisions for patients with early-stage breast cancer treated under the public health care system in Brazil, Sistema Único de Saúde. METHODS Eligible patients treated at Hospital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a828facd7ec6db251075fb4cc77027a
https://doi.org/10.1200/go.20.00609
https://doi.org/10.1200/go.20.00609
Publikováno v:
Mastology.
Objective: The aim of this study was to evaluate HER2-negative estrogen receptor and or progesterone receptor positive and describe treatments and overall survival (OS) of patients treated in a reference center. Methods: We enrolled retrospectively 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::373550a16e96239f321d45c4d6dc66c2
https://doi.org/10.29289/259453942022v32s2041
https://doi.org/10.29289/259453942022v32s2041
Autor:
Mauro Orlando Meurer Oliveira, Jorge Yoshinori Shida, André Mattar, Felipe Andreotta Cavagna, Luiz Henrique Gebrim
Publikováno v:
Mastology.
Introduction: Clinical staging (CS) has great importance for therapeutic programming and prognostic evaluation in patients diagnosed with breast cancer. Malignant breast tumors can be classified according to their immunohistochemical (IHC) profile. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf620e5b0d3d73eb3bbf0e06533ebd84
https://doi.org/10.29289/259453942021v31s1035
https://doi.org/10.29289/259453942021v31s1035
Publikováno v:
Mastology.
Introduction: According to estimates from the Brazilian Department of Health, in 2021 we will see more than 65,000 cases of breast cancer in Brazil. The predominance of advanced cases in the Brazilian Unified Health System (SUS) stems from the long t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa6df80d3be1e897922ee1d5337c6c7f
https://doi.org/10.29289/259453942021v31s1024
https://doi.org/10.29289/259453942021v31s1024
Autor:
Mayane Freitas Desiderio, Marcela Bonalumi Santos, André Mattar, Jorge Yoshinori Shida, Luiz Henrique Gebrim
Publikováno v:
Mastology.
Introduction: The pathologic complete response (pCR) definition after neoadjuvant chemotherapy (NAC) for breast cancer is better defined as the absence of residual invasive cancer, although it allows the presence of ductal carcinoma in situ (DCIS). I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c7de0ea5cc514c3a7844843ed0c2634
https://doi.org/10.29289/259453942021v31s1087
https://doi.org/10.29289/259453942021v31s1087
Autor:
Paola Ferreira Freitas, Juliana Costa Souza, Andre Mattar, Jorge Yoshinori Shida, Luiz Henrique Gebrim
Publikováno v:
Mastology.
Introduction: Luminal breast cancer cases, those with positive hormone receptors and human epidermal growth factor (HER 2) negative range around 70% of cases and it is known to be more frequent in older patients. Out of the neoadjuvant therapies, neo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e93c0d8fe9e887b3cc291f8d996e4a0
https://doi.org/10.29289/259453942021v31s1086
https://doi.org/10.29289/259453942021v31s1086
Publikováno v:
Mastology.
Introduction: Breast cancer is the most frequent cause of cancer death in women, also haunting them because surgical treatment can vary from expanded resection to mastectomy, causing aesthetic, functional, psychological and social damage. In Brazil,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fe920927b6cc373bc18cc7729831041
https://doi.org/10.29289/259453942021v31s1066
https://doi.org/10.29289/259453942021v31s1066
Autor:
Nathália Karina Abreu, Bruno Neto Martins Aguiar, André Mattar, Jorge Yoshinori Shida, Luiz Henrique Gebrim
Publikováno v:
Mastology.
Introduction: Breast cancer in Brazil has a high mortality rate due to the large number of patients diagnosed and treated in advanced stages, due to lack of an organized screening program and the long time from diagnosis to initiation of treatment in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c02ea3c7eb006fee5d23ea2ecc3f0dc
https://doi.org/10.29289/259453942021v31s1056
https://doi.org/10.29289/259453942021v31s1056
Autor:
Igor Duarte de Oliveira, Jorge Yoshinori Shida, André Mattar, Silvana Maria Graziani, Luiz Henrique Gebrim
Publikováno v:
Mastology.
Introduction: In 2021, it is estimated that Brazil will have 66,280 new cases of breast cancer. Unfortunately, around 55% of the cases treated by the Brazilian Unified Health System (SUS) are symptomatic and are in advanced stages. The long time befo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d5587c33c12ebe15645211e41030ab2
https://doi.org/10.29289/259453942021v31s1009
https://doi.org/10.29289/259453942021v31s1009
Autor:
Marina Diogenes Teixeira, Felipe Andreotta Cavagna, Jorge Yoshinori Shida, Andre Mattar, Luiz Henrique Gebrim
Publikováno v:
Mastology.
Introduction: Over the last few decades, neoadjuvant chemotherapy (NCT) has played an increasing role in the management of breast cancer. It allows for an evaluation of the tumour reponse in vivo and may afford a de-escalation of surgeries. Despite a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7252ea3ec93b6f1594e48b671fe0fd60
https://doi.org/10.29289/259453942021v31s1067
https://doi.org/10.29289/259453942021v31s1067